Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04747600
Status:
COMPLETED
Last Update Posted:
2022-10-10
First Post:
2021-02-07
Brief Title:
Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement A Prospective Observational Study
Sponsor:
Zagazig University
Organization:
Zagazig University
Study Overview
Official Title:
Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement A Prospective Observational Study
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Introduction Pancreatic cystic neoplasms PCNs comprise neoplasms with a wide range of benign and malignant varieties The most common include serous cystic neoplasms SCNs mucinous cystic neoplasms MCNs intraductal papillary mucinous neoplasms IPMNs and solid pseudo-papillary neoplasms SPPNs
Endoscopic ultrasonography EUS computed tomography CT and magnetic resonance MR are used to diagnose different PCNs types The cyst fluid aspiration and analysis is performed in difficult differential diagnosis Frequently amylase and CEA levels are measured The choice of surgery depends on cyst location and size and includes pancreatico-duodenectomy or distal pancreatectomy
Objectives The aim of this study was to evaluate the outcomes after pancreatic surgery when adopted as the management of true exocrine epithelial cystic neoplasms
Endoscopic ultrasonography EUS computed tomography CT and magnetic resonance MR are used to diagnose different PCNs types The cyst fluid aspiration and analysis is performed in difficult differential diagnosis Frequently amylase and CEA levels are measured The choice of surgery depends on cyst location and size and includes pancreatico-duodenectomy or distal pancreatectomy
Objectives The aim of this study was to evaluate the outcomes after pancreatic surgery when adopted as the management of true exocrine epithelial cystic neoplasms
Detailed Description:
Introduction Pancreatic cystic neoplasms PCNs comprise neoplasms with a wide range of benign and malignant varieties The most common include serous cystic neoplasms SCNs mucinous cystic neoplasms MCNs intraductal papillary mucinous neoplasms IPMNs and solid pseudo-papillary neoplasms SPPNs
Endoscopic ultrasonography EUS computed tomography CT and magnetic resonance MR are used to diagnose different PCNs types The cyst fluid aspiration and analysis is performed in difficult differential diagnosis Frequently amylase and CEA levels are measured The choice of surgery depends on cyst location and size and includes pancreatico-duodenectomy or distal pancreatectomy
Objectives The aim of this study was to evaluate the outcomes after pancreatic surgery when adopted as the management of true exocrine epithelial cystic neoplasms
Patients and methods Between June 2014 and January 2018 63 patients referred to our tertiary referral center with diagnosis of true exocrine cystic neoplasms of the pancreas accepted for surgery were included in the present prospective cohort study Patients were categorized according to preoperative diagnosis into serous cystic neoplasms Group A 30 patients mucinous cystic neoplasms Group B 13 patients intra-papillary mucinous neoplasms Group C 9 patients whereas the last 5 patients diagnosed as solid pseudo-papillary neoplasms Group D Demographic data perioperative data and univariate analysis for malignancy recurrence and pancreatic fistula were collected and analyzed
Endoscopic ultrasonography EUS computed tomography CT and magnetic resonance MR are used to diagnose different PCNs types The cyst fluid aspiration and analysis is performed in difficult differential diagnosis Frequently amylase and CEA levels are measured The choice of surgery depends on cyst location and size and includes pancreatico-duodenectomy or distal pancreatectomy
Objectives The aim of this study was to evaluate the outcomes after pancreatic surgery when adopted as the management of true exocrine epithelial cystic neoplasms
Patients and methods Between June 2014 and January 2018 63 patients referred to our tertiary referral center with diagnosis of true exocrine cystic neoplasms of the pancreas accepted for surgery were included in the present prospective cohort study Patients were categorized according to preoperative diagnosis into serous cystic neoplasms Group A 30 patients mucinous cystic neoplasms Group B 13 patients intra-papillary mucinous neoplasms Group C 9 patients whereas the last 5 patients diagnosed as solid pseudo-papillary neoplasms Group D Demographic data perioperative data and univariate analysis for malignancy recurrence and pancreatic fistula were collected and analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None